PHARMACOLOGICAL CRITERIA FOR THE TESTING OF ANTI-CANCER DRUGS

被引：0
|
作者：
DRUCKREY, H
机构：
来源：
ACTA UNIO INTERNATIONALIS CONTRA CANCRUM | 1957年 / 13卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：382 / 392
页数：11
相关论文
共 50 条
  • [1] TESTING ANTI-CANCER DRUGS
    不详
    [J]. LANCET, 1972, 1 (7755): : 827 - +
  • [2] TESTING ANTI-CANCER DRUGS
    BERENBAUM, MC
    SHEARD, CE
    [J]. LANCET, 1972, 1 (7760): : 1116 - +
  • [3] TESTING ANTI-CANCER DRUGS
    MITCHELL, JS
    DAWSON, MPA
    DENDY, PP
    WHEELER, TK
    [J]. LANCET, 1972, 1 (7757): : 955 - &
  • [4] Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs
    Su, Yanwei
    Zhao, Bin
    Zhou, Liangfu
    Zhang, Zheyuan
    Shen, Ying
    Lv, Huanhuan
    AlQudsy, Luban Hamdy Hameed
    Shang, Peng
    [J]. CANCER LETTERS, 2020, 483 : 127 - 136
  • [5] A novel pharmacological mechanism of anti-cancer drugs that induce pyroptosis
    Haohao Guo
    Ziyang Wang
    Runsheng Ma
    Xin Chen
    Hongqiang Li
    Yifeng Tang
    Gongbo Du
    Yifei Zhang
    Detao Yin
    [J]. Inflammopharmacology, 2023, 31 : 745 - 754
  • [6] A novel pharmacological mechanism of anti-cancer drugs that induce pyroptosis
    Guo, Haohao
    Wang, Ziyang
    Ma, Runsheng
    Chen, Xin
    Li, Hongqiang
    Tang, Yifeng
    Du, Gongbo
    Zhang, Yifei
    Yin, Detao
    [J]. INFLAMMOPHARMACOLOGY, 2023, 31 (02) : 745 - 754
  • [7] Anti-cancer drugs
    Bergmann-Leitner, ES
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (09) : 1077 - 1078
  • [8] Anti-cancer drugs
    Bergmann-Leitner, Elke
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (11) : 1048 - 1048
  • [9] Anti-Cancer Drugs
    Bergmann-Leitner, Elke
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (07) : 730 - 731
  • [10] Pharmacological Profile and Pharmacogenomics of Anti-Cancer Drugs Used for Targeted Therapy
    Di Francia, Raffaele
    De Monaco, Angela
    Saggese, Mariangela
    Iaccarino, Giancarla
    Crisci, Stefania
    Frigeri, Ferdinando
    De Filippi, Rosaria
    Berretta, Massimiliano
    Pinto, Antonio
    [J]. CURRENT CANCER DRUG TARGETS, 2018, 18 (05) : 499 - 511
12345